Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitization.

< BACK TO ARCHIVE


Papers: 26 Dec 2020 - 1 Jan 2021


Human Studies, Pharmacology/Drug Development


2020 Nov-Dec


Pain Rep


http://www.ncbi.nlm.nih.gov/pubmed/33364540?dopt=Abstract


5


6

Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitization.

Authors

Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitization.
van de Donk T, van Cosburgh J, van Dasselaar T, van Velzen M, Drewes A M, Dahan A, Niesters M
Pain Rep. 2020 Nov-Dec; 5(6):e877.
PMID: 33364540.

Abstract

Chronic low back pain (CLBP) is one of the most common chronic pain conditions in pain practice.
Read This Paper